Shorter individuals twice as likely to develop esophageal cancer
the ONA take:
According to a new study published in the journal Clinical Gastroenterology and Hepatology, researchers at Fred Hutchinson Cancer Research Center in Seattle, Washington, have found that taller individuals are less likely to develop Barrett's esophagus and esophageal cancer than shorter individuals.
For the study, the researchers analyzed data from 14 studies within the International Barrett's and Esophageal Adenocarcinoma Consortium (BEACON). They found that those in the lowest quartile of height, or men under 5'7" and women under 5'2", were approximately twice as likely as those in the highest quartile of height, or men taller than 6' and women taller than 5'5", to have esophageal cancer or Barrett's esophagus.
Bases on analyses, results were consistent among various other factors, including age, body mass index, education, gastroesophageal reflux disease (GERD) symptoms, sex, and smoking. Researchers suggest that height may be able to be used as a risk factors to identify patients with a higher risk of developing Barrett's esophagus or esophageal cancer. Of note, the relationship between height and esophageal cancer observed in this study is the opposite of what has been observed in breast, colorectal, and prostate cancers.
Taller individuals are less likely to develop Barrett's esophagus and esophageal cancer.
A new study has observed that tall people are less likely to suffer from esophageal cancer as compared to short people.
The study conducted a large pooled analysis using data from 14 population-based epidemiologic studies within the International Barrett's and Esophageal Adenocarcinoma Consortium (BEACON), including 1,000 cases of esophageal cancer and twice as many cases of Barrett's esophagus, and twice as many controls.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|